Year: 2021
Type: article
Abstract: The Great Debate session at the 2020 Melanoma Bridge virtual congress (December 3rd-5th, Italy) featured counterpoint views from experts on five specific controversial issues in melanoma. The debates considered whether or not innate immunity is important in the response to cancer and immunotherapy, how useful are the revised American Joint Committee on Cancer (AJCC) classification for the staging of patients, the use of sentinel node biopsy for staging patients, the use of triplet combination of targeted therapy plus immunotherapy versus combined immunotherapy, and the respective benefits of neoadjuvant versus adjuvant therapy. As is usual with Bridge congresses, the debates were assigned by meeting Chairs and positions taken by experts during the debates may not have necessarily reflected their own personal opinion.
Institutions: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Georgetown Lombardi Comprehensive Cancer Center, University Medical Center Utrecht, Princess Máxima Center, The University of Texas MD Anderson Cancer Center, Aix-Marseille Université, Hôpital de la Timone, Angeles Clinic and Research Institute, University of South Florida, Moffitt Cancer Center, Richard M. Schulze Family Foundation, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, NYU Langone Health, Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,990
OpenAlex ID: W3145951778